Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Giuseppe Remuzzi, … , Ariela Benigni, Andrea Remuzzi
Giuseppe Remuzzi, … , Ariela Benigni, Andrea Remuzzi
Published February 1, 2006
Citation Information: J Clin Invest. 2006;116(2):288-296. https://doi.org/10.1172/JCI27699.
View: Text | PDF
Science in Medicine Article has an altmetric score of 10

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

  • Text
  • PDF
Abstract

The incidence of chronic kidney diseases is increasing worldwide, and these conditions are emerging as a major public health problem. While genetic factors contribute to susceptibility and progression of renal disease, proteinuria has been claimed as an independent predictor of outcome. Reduction of urinary protein levels by various medications and a low-protein diet limits renal function decline in individuals with nondiabetic and diabetic nephropathies to the point that remission of the disease and regression of renal lesions have been observed in experimental animals and even in humans. In animal models, regression of glomerular structural changes is associated with remodeling of the glomerular architecture. Instrumental to this discovery were 3D reconstruction studies of the glomerular capillary tuft, which allowed the quantification of sclerosis volume reduction and capillary regeneration upon treatment. Regeneration of capillary segments might result from the contribution of resident cells, but progenitor cells of renal or extrarenal origin may also have a role. This review describes recent advances in our understanding of the mechanisms and mediators underlying renal tissue repair ultimately responsible for regression of renal injury.

Authors

Giuseppe Remuzzi, Ariela Benigni, Andrea Remuzzi

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 6 9 14 14 7 7 12 13 13 14 11 23 18 18 10 14 6 1 1 211
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (211)

Title and authors Publication Year
Correlation between ultrafiltration rate and hemoglobin level and erythropoietin response in hemodialysis patients.
Cui L, Zhang L, Li J, Li Y, Hao X, Xu Y, Li C
Renal Failure 2024
Fractional Excretion of Urate is Positively Associated with Type 2 Diabetes in HUA Patients: A Cross-Sectional Study
Huang B, Li X, Zhang X, Li S, Liu Y, Zhang M, Cui J
2024
Therapeutic potential of vitamin D3 in mitigating high glucose‑induced renal damage: Mechanistic insights into oxidative stress inhibition and TXNIP/NLRP3 signaling pathway blockade
Li G, He S, Liu T, Zheng N
Experimental and therapeutic medicine 2024
Untangling the Uncertain Role of Overactivation of the Renin–Angiotensin–Aldosterone System with the Aging Process Based on Sodium Wasting Human Models
Thimm C, Adjaye J
International Journal of Molecular Sciences 2024
Chronic Complications of Diabetes: Prevalence, Prevention, and Management
Migdalis IN
Journal of Clinical Medicine 2024
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications
León-Jiménez D, Sridhar VS, López-Mendoza M, Scholtes RA, Schmieder RE, Cherney DZ, van Raalte DH, Toro-Prieto FJ, Miramontes-González JP, van Bommel EJ
Clinical Kidney Journal 2024
Hepatocyte Nuclear Factor 4 alpha 2 is a novel osteoblast transcription factor that regulates osteogenesis
Marta Martinez-Calle, Guillaume Courbon, Bridget Hunt-Tobey, Connor Francis, Jadeah Spindler, Xueyan Wang, Luciene M. dos Reis, Carolina Steller Wagner Martins, Isidro Salusky, Hartmut H Malluche, Thomas L Nickolas, Rosa M.A. Moyses, Aline Martin, Valentin David
Journal of Clinical Investigation 2023
Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes
Thimm C, Erichsen L, Wruck W, Adjaye J
International journal of molecular sciences 2023
Molecular MR Imaging of Renal Fibrogenesis in Mice
Chen YC, Waghorn PA, Rosales IA, Arora G, Erstad DJ, Rotile NJ, Jones CM, Ferreira DS, Wei L, Martinez RV, Schlerman FJ, Wellen J, Fuchs BC, Colvin RB, Ay I, Caravan P
Journal of the American Society of Nephrology : JASN 2023
Contemporary Biomarkers for Renal Transplantation: A Narrative Overview.
Novacescu D, Latcu SC, Bardan R, Daminescu L, Cumpanas AA
Journal of Personalized Medicine 2023
Female but Not Male Mice Deficient in Soluble IgM Are Susceptible to Chemically Induced Glomerular Injury.
Whelan R, Feemster A, Laskowski J, Renner B, Kulik L, Poppelaars F, Lee C, Holers VM, Thurman JM
Journal of immunology (Baltimore, Md. : 1950) 2023
Treatment of IgA Nephropathy: A Rapidly Evolving Field.
El Karoui K, Fervenza FC, De Vriese AS
Journal of the American Society of Nephrology : JASN 2023
Development of an automated estimation of foot process width using deep learning in kidney biopsies from patients with Fabry, minimal change, and diabetic kidney diseases.
Smerkous D, Mauer M, Tøndel C, Svarstad E, Gubler MC, Nelson RG, Oliveira JP, Sargolzaeiaval F, Najafian B
Kidney International 2023
Nutritional Treatment as a Synergic Intervention to Pharmacological Therapy in CKD Patients.
Giannese D, D'Alessandro C, Panichi V, Pellegrino N, Cupisti A
Nutrients 2023
Role of arterial hypertension and angiotensin II in chronic kidney disease (Review).
Maranduca MA, Clim A, Pinzariu AC, Statescu C, Sascau RA, Tanase DM, Serban DN, Branisteanu DC, Branisteanu DE, Huzum B, Serban IL
Experimental and therapeutic medicine 2023
The Pathology Lesion Patterns of Podocytopathies: How and why?
F Ravaglia, M Melica, M Angelotti, L Chiara, P Romagnani, L Lasagni
Frontiers in Cell and Developmental Biology 2022
Lipocalin-2: a novel link between the injured kidney and the bone
Courbon G, David V
Current Opinion in Nephrology and Hypertension 2022
Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection.
Haruhara K, Kanzaki G, Tsuboi N
Hypertension research : official journal of the Japanese Society of Hypertension 2022
Yi Shen An, a Chinese traditional prescription, ameliorates membranous glomerulonephritis induced by cationic bovine serum albumin in rats.
Zhao YL, Zhang XH, Guo F, Wei Y, Shang JH, Luo XD
Pharmaceutical Biology 2022
Lipocalin 2—not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials
Asaf S, Maqsood F, Jalil J, Sarfraz Z, Sarfraz A, Mustafa S, Ojeda IC
Immunologic research 2022
Integrated virtual medical consultations versus traditional clinic care in a public and a private outpatient service.
Katz I, Lane C, Pirabhahar S, Williamson P, Kelly J, Preece R, Raghunath V, Brown M
2022
Urine-Based Detection of Biomarkers Indicative of Chronic Kidney Disease in a Patient Cohort from Ghana.
Wruck W, Boima V, Erichsen L, Thimm C, Koranteng T, Kwakyi E, Antwi S, Adu D, Adjaye J
Journal of Personalized Medicine 2022
Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study.
Gao Z, Zhu Y, Sun X, Zhu H, Jiang W, Sun M, Wang J, Liu L, Zheng H, Qin Y, Zhang S, Yang Y, Xu J, Yang J, Shan C, Chang B
Frontiers in Endocrinology 2022
Development of Cell Therapies for Renal Disease and Regenerative Medicine.
Torrico S, Hotter G, Játiva S
International journal of molecular sciences 2022
Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy.
Lv X, Wang J, Zhang L, Shao X, Lin Y, Liu H, Ma G, Li J, Zhou S, Yu P
Frontiers in immunology 2022
Extracellular vesicles metabolic changes reveals plasma signature in stage-dependent diabetic kidney disease.
Pan Y, Yang H, Chen T, Jin J, Ruan L, Hu L, Chen L
Renal Failure 2022
Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease.
Ames MK, Vaden SL, Atkins CE, Palerme JS, Langston CE, Grauer GF, Shropshire S, Bove C, Webb T
Journal of Veterinary Internal Medicine 2022
Association of dietary inflammatory index with chronic kidney disease and kidney stones in Iranian adults: A cross-sectional study within the Ravansar non-communicable diseases cohort.
Moludi J, Fateh HL, Pasdar Y, Moradinazar M, Sheikhi L, Saber A, Kamari N, Bonyani M, Najafi F, Dey P
Frontiers in Nutrition 2022
Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN).
Vaisbich MH, Andrade LGM, Silva CAB, Barreto FC
Jornal Brasileiro de Nefrologia 2022
Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
H Yeh, CC Chiang, TH Yen
World journal of gastroenterology : WJG 2021
Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
A Chen, H Wang, Y Su, C Zhang, Y Qiu, Y Zhou, Y Wan, B Hu, Y Li
Frontiers in Endocrinology 2021
Total Nephron Number and Single-Nephron Parameters in Patients with IgA Nephropathy
H Marumoto, N Tsuboi, V DAgati, T Sasaki, Y Okabayashi, K Haruhara, G Kanzaki, K Koike, A Shimizu, T Kawamura, A Rule, J Bertram, T Yokoo
2021
Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes
T Yasuzawa, T Nakamura, S Ueshima, A Mima, A Sugawara
Journal of Diabetes Research 2021
The Associations of Plasma Biomarkers of Inflammation with Histopathologic Lesions, Kidney Disease Progression, and Mortality - The Boston Kidney Biopsy Cohort Study
A Srivastava, IM Schmidt, R Palsson, A Weins, JV Bonventre, V Sabbisetti, IE Stillman, HG Rennke, SS Waikar
Kidney International Reports 2021
Chronic Kidney Disease: Strategies to Retard Progression
MT Yan, CT Chao, SH Lin
International journal of molecular sciences 2021
Uncoupling Protein 2 Expression Modulates Obesity in Chronic Kidney Disease Patients
SA Shawky, O Gaber, E Mostafa, WM Sarhan
Reports of Biochemistry & Molecular Biology 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial
F Carrara, P Ruggenenti, A Perna, IP Iliev, F Gaspari, S Ferrari, N Stucchi, A Bossi, R Trevisan, G Remuzzi, A Parvanova
Acta Diabetologica 2021
Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling
Y Yang, Y Lei, Y Liang, S Fu, C Yang, K Liu, Y Chen
International Urology and Nephrology 2021
Static and Dynamic Prediction of Chronic Renal Disease Progression Using Longitudinal Clinical Data from Taiwan's National Prevention Programs.
Chang YP, Liao CM, Wang LH, Hu HH, Lin CM
Journal of Clinical Medicine 2021
Weight loss reduces the incidence of dipstick proteinuria: a cohort study from the Japanese general population.
Nagai K, Yamagata K, Iseki K, Moriyama T, Tsuruya K, Fujimoto S, Narita I, Konta T, Kondo M, Kasahara M, Shibagaki Y, Asahi K, Watanabe T
Clinical and Experimental Nephrology 2021
Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region.
Li PKT, Choy ASM, Bavanandan S, Chen W, Foo M, Kanjanabuch T, Kim YL, Nakayama M, Yu X
2021
Searching for Potential Markers of Glomerulopathy in Urine by HS-SPME-GC×GC TOFMS.
Ligor T, Zawadzka J, Strączyński G, González Paredes RM, Wenda-Piesik A, Ratiu IA, Muszytowski M
Molecules (Basel, Switzerland) 2021
CKD subpopulations defined by risk-factors: A longitudinal analysis of electronic health records.
Ramaswamy R, Wee SN, George K, Ghosh A, Sarkar J, Burghaus R, Lippert J
The Journal of Pathology 2021
Signaling pathways predisposing to chronic kidney disease progression
Mohamad Zaidan, Martine Burtin, Jitao David Zhang, Thomas Blanc, Pauline Barre, Serge Garbay, Clement Nguyen, Florence Vasseur, Lucie Yammine, Serena Germano, Laura Badi, Marie-Claire Gubler, Morgan Gallazzini, Gerard Friedlander, Marco Pontoglio, Fabiola Terzi
JCI Insight 2020
Role of ultrastructural determinants of glomerular permeability in ultrafiltration function loss
Andrea Remuzzi, Sara Conti, Bogdan Ene-Iordache, Susanna Tomasoni, Paola Rizzo, Ariela Benigni, Giuseppe Remuzzi
JCI Insight 2020
Kynurenine/Tryptophan Ratio Predicts Angiotensin Receptor Blocker Responsiveness in Patients with Diabetic Kidney Disease
MH Wu, CN Lin, DT Chiu, ST Chen
Diagnostics 2020
Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease
MA Egerman, JS Wong, T Runxia, G Mosoyan, K Chauhan, J ReyesBahamonde, N Anandakrishnan, NJ Wong, E Bagiella, F Salem, K Meliambro, H Li, EU Azeloglu, SG Coca, KN Campbell, L Raij
The FASEB Journal 2020
Association of Proteinuria with Urinary Concentration Defect in Puromycin Aminonucleoside Nephrosis
CH Jo, S Kim, GH Kim
Electrolyte & blood pressure : E & BP 2020
Lin28a attenuates TGF-β-induced renal fibrosis.
Jung GS, Hwang YJ, Choi JH, Lee KM
BMB Reports 2020
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease.
Watson AMD, Gould EAM, Moody SC, Sivakumaran P, Sourris KC, Chow BSM, Koïtka-Weber A, Allen TJ, Jandeleit-Dahm KAM, Cooper ME, Calkin AC
Frontiers in physiology 2020
The renin-angiotensin-aldosterone system and its suppression
MK Ames, CE Atkins, B Pitt
Journal of Veterinary Internal Medicine 2019
Inhibition of Soluble Epoxide Hydrolase for Renal Health
JY Liu
Frontiers in pharmacology 2019
Biopsy-based estimation of total nephron number in Japanese living kidney donors
T Sasaki, N Tsuboi, G Kanzaki, K Haruhara, Y Okabayashi, K Koike, A Kobayashi, I Yamamoto, M Ogura, WE Hoy, JF Bertram, A Shimizu, T Yokoo
Clinical and Experimental Nephrology 2019
Estimation of nephron number in living humans by combining unenhanced computed tomography with biopsy-based stereology
T Sasaki, N Tsuboi, Y Okabayashi, K Haruhara, G Kanzaki, K Koike, A Kobayashi, I Yamamoto, S Takahashi, T Ninomiya, A Shimizu, AD Rule, JF Bertram, T Yokoo
Scientific Reports 2019

Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa


AM Nalado, J Mahlangu, B Waziri, R Duarte, G Paget, G Olorunfemi, S Naicker
International journal of nephrology and renovascular disease 2019
Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury
J Wang, D Fu, S Senouthai, Y You
Molecular medicine reports 2019
Protective Role of Angiotensin Type 1 Receptor Blockade in 4/6 Nephrectomized Male and Female Rats.
Moeini M, Talebi A, Nematbakhsh M
International journal of preventive medicine 2019
The role of klotho in chronic kidney disease
D Zou, W Wu, Y He, S Ma, J Gao
BMC Nephrology 2018
Exploring macrophage cell therapy on Diabetic Kidney Disease
R Guiteras, A Sola, M Flaquer, A Manonelles, G Hotter, JM Cruzado
Journal of Cellular and Molecular Medicine 2018
Efficacy of low-dose spironolactone on top of angiotensin receptor blockade in patients with glomerulonephritis
BC Yu, MS Lee, JJ Moon, SJ Choi, JK Kim, SD Hwang, MY Park
Kidney Research and Clinical Practice 2018
Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.
Peng CH, Lin HC, Lin CL, Wang CJ, Huang CN
Journal of Food and Drug Analysis 2018
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.
Weir MA, Walsh M, Cuerden MS, Sontrop JM, Chambers LC, Garg AX
Canadian Journal of Kidney Health and Disease 2018
Infusion of autologous bone marrow derived mononuclear stem cells potentially reduces urinary markers in diabetic nephropathy.
Gaipov A, Taubaldiyeva Z, Askarov M, Turebekov Z, Kozina L, Myngbay A, Ulyanova O, Tuganbekova S
Journal of Nephrology 2018
Prevalence, socio-demographic characteristics, and comorbid health conditions in pre-dialysis chronic kidney disease: results from the Manitoba chronic kidney disease cohort.
Chartier MJ, Tangri N, Komenda P, Walld R, Koseva I, Burchill C, McGowan KL, Dart A
BMC Nephrology 2018
Hyperglycemia activates the renin-angiotensin system and induces epithelial-mesenchymal transition in streptozotocin-induced diabetic kidneys.
Chen CM, Juan SH, Chou HC
Journal of the renin-angiotensin-aldosterone system : JRAAS 2018
Diabetic nephropathy: newer therapeutic perspectives.
Keri KC, Samji NS, Blumenthal S
Journal of Community Hospital Internal Medicine Perspectives 2018
Angiotensin II Modulates Podocyte Glucose Transport.
Lewko B, Maryn A, Latawiec E, Daca A, Rybczynska A
Frontiers in Endocrinology 2018
The toxicological mechanisms and detoxification of depleted uranium exposure.
Yue YC, Li MH, Wang HB, Zhang BL, He W
Environmental Health and Preventive Medicine 2018
Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study.
Iimori S, Naito S, Noda Y, Sato H, Nomura N, Sohara E, Okado T, Sasaki S, Uchida S, Rai T
PloS one 2018
Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis
Y Hosoe-Nagai, T Hidaka, A Sonoda, Y Sasaki, K Yamamoto-Nonaka, T Seki, R Asao, E Tanaka, JA Trejo, F Kodama, M Takagi, N Tada, T Ueno, R Nishinakamura, Y Tomino, K Asanuma
Laboratory Investigation 2017
Prorenin receptor mediates inflammation in renal ischemia
SS Quadri, S Culver, HM Siragy
Clinical and experimental pharmacology & physiology 2017
Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology
N Perico, F Casiraghi, G Remuzzi
Journal of the American Society of Nephrology : JASN 2017
Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies
A Nogueira, MJ Pires, PA Oliveira
In vivo (Athens, Greece) 2017
Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update
YM Chen, WC Chiang, SL Lin, TJ Tsai
Journal of Biomedical Science 2017
Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
Bjornstad P, Nehus E, El Ghormli L, Bacha F, Libman IM, McKay S, Willi SM, Laffel L, Arslanian S, Nadeau KJ
American journal of kidney diseases : the official journal of the National Kidney Foundation 2017
Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G, Song L, Chen Z, Qian Y, Xie J, Zhao L, Lin Q, Zhu G, Tan Y, Li X, Mohammadi M, Huang Z
Kidney International 2017
Treatment of membranous nephropathy: time for a paradigm shift.
Ruggenenti P, Fervenza FC, Remuzzi G
Nature reviews. Nephrology 2017
Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.
Okechuku GO, Shoemaker LR, Dambska M, Brown LM, Mathew J, Weinstein DA
Journal of Inherited Metabolic Disease 2017
Urinary extracellular vesicles. A promising shortcut to novel biomarker discoveries.
Barreiro K, Holthofer H
Cell and Tissue Research 2017
Sodium glucose transporter-2 inhibition has no renoprotective effects on non-diabetic chronic kidney disease.
Ma Q, Steiger S, Anders HJ
Physiological Reports 2017
Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats.
Nakanishi K, Nagai Y, Akimoto T, Yamanaka N
Journal of Smooth Muscle Research 2017
An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis
Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, Tuller S, Perumal K, Massengill SF, Kamil ES, Oh G, Selewski DT, Gipson P, Gipson DS
Clinical journal of the American Society of Nephrology : CJASN 2017
Inflammation regulates fibroblast growth factor 23 production:
C Francis, V David
Current Opinion in Nephrology and Hypertension 2016
Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30–40 days of postnatal corrected age
MC Aisa, B Cappuccini, A Barbati, A Orlacchio, M Baglioni, GC di Renzo
Pediatric Nephrology 2016
Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1
HW Lee, SQ Khan, S Khaliqdina, MM Altintas, F Grahammer, JL Zhao, KH Koh, NJ Tardi, MH Faridi, T Geraghty, DJ Cimbaluk, K Susztak, LF Moita, D Baltimore, PL Tharaux, TB Huber, M Kretzler, M Bitzer, J Reiser, V Gupta
The Journal of biological chemistry 2016
Macrophage in chronic kidney disease
R Guiteras, M Flaquer, JM Cruzado
Clinical Kidney Journal 2016
Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2
KE Karoui, A Viau, O Dellis, A Bagattin, C Nguyen, W Baron, M Burtin, M Broueilh, L Heidet, G Mollet, A Druilhe, C Antignac, B Knebelmann, G Friedlander, F Bienaimé, M Gallazzini, F Terzi
Nature Communications 2016
Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease
KG Avin, NX Chen, JM Organ, C Zarse, K ONeill, RG Conway, RJ Konrad, RL Bacallao, MR Allen, SM Moe, NO Câmara
PloS one 2016
Angiotensin II Modulates p130Cas of Podocytes by the Suppression of AMP-Activated Protein Kinase
TS Ha, HY Park, SB Seong, HY Ahn
Journal of Korean Medical Science 2016
Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress
L Raij, R Tian, JS Wong, JC He, KN Campbell
American journal of physiology. Renal physiology 2016
Effect of telmisartan on kidney function in patients with chronic kidney disease: an observational study.
Agrawal A, Kamila S, Reddy S, Lilly J, Mariyala MS
Journal of Drug Assessment 2016
Comparative evaluation of nephroprotective potential of resveratrol and piperine on nephrotic BALB/c mice.
Kakalij RM, Kumar BD, Diwan PV
Indian journal of pharmacology 2016
Status of stem cells in diabetic nephropathy: predictive and preventive potentials.
Baban B, Liu JY, Payne S, Abebe W, Yu JC, Mozaffari MS
The EPMA Journal 2016
Lessons from genetics: is it time to revise the therapeutic approach to children with steroid-resistant nephrotic syndrome?
Becherucci F, Mazzinghi B, Provenzano A, Murer L, Giglio S, Romagnani P
Journal of Nephrology 2016
Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.
Bjornstad P, Cherney DZ, Maahs DM, Nadeau KJ
Current Diabetes Reports 2016
Regression of Renal Disease by Angiotensin II Antagonism Is Caused by Regeneration of Kidney Vasculature
A Remuzzi, F Sangalli, D Macconi, S Tomasoni, I Cattaneo, P Rizzo, B Bonandrini, E Bresciani, L Longaretti, E Gagliardini, S Conti, A Benigni, G Remuzzi
Journal of the American Society of Nephrology : JASN 2015
Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced
L Lasagni, ML Angelotti, E Ronconi, D Lombardi, S Nardi, A Peired, F Becherucci, B Mazzinghi, A Sisti, S Romoli, A Burger, B Schaefer, A Buccoliero, E Lazzeri, P Romagnani
Stem Cell Reports 2015
Endothelin and the Glomerulus in Chronic Kidney Disease
M Barton, A Sorokin
Seminars in Nephrology 2015
Adult stem-like cells in kidney
K Hishikawa
World journal of stem cells 2015
Recent advances in understanding of chronic kidney disease
J Yamaguchi, T Tanaka, M Nangaku
F1000Research 2015
Angiotensin II induces endoplasmic reticulum stress in podocyte, which would be further augmented by PI3-kinase inhibition
TS Ha, HY Park, SB Seong, HY Ahn
Clinical Hypertension 2015
Risk of proteinuria among individuals with persistent borderline diabetes: the Saku study.
Tatsumi Y, Morimoto A, Soyano F, Shimoda T, Miyamatsu N, Ohno Y, Sakaguchi S
Diabetology International 2015
Hyperfiltration and uricosuria in adolescents with type 1 diabetes.
Bjornstad P, Roncal C, Milagres T, Pyle L, Lanaspa MA, Bishop FK, Snell-Bergeon JK, Johnson RJ, Wadwa RP, Maahs DM
Pediatric nephrology (Berlin, Germany) 2015
Deteriorated glucose metabolism with a high-protein, low-carbohydrate diet in db mice, an animal model of type 2 diabetes, might be caused by insufficient insulin secretion.
Arimura E, Pulong WP, Marchianti ACN, Nakakuma M, Abe M, Ushikai M, Horiuchi M
European Journal of Nutrition 2015
Epidemiology of CKD Regression in Patients under Nephrology Care.
Borrelli S, Leonardis D, Minutolo R, Chiodini P, De Nicola L, Esposito C, Mallamaci F, Zoccali C, Conte G
PloS one 2015
Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes.
Bjornstad P, Cherney DZ, Snell-Bergeon JK, Pyle L, Rewers M, Johnson RJ, Maahs DM
Nephrology Dialysis Transplantation 2015
Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy.
Musante L, Tataruch D, Gu D, Liu X, Forsblom C, Groop PH, Holthofer H
Journal of Diabetes Research 2015
Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection.
Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD
Clinical Pharmacology & Therapeutics 2015
Scaffolds from surgically removed kidneys as a potential source of organ transplantation.
Karczewski M, Malkiewicz T
BioMed Research International 2015
Hypertension and Hyperglycemia Synergize to Cause Incipient Renal Tubular Alterations Resulting in Increased NGAL Urinary Excretion in Rats
AM Blázquez-Medela, O García-Sánchez, V Blanco-Gozalo, Y Quiros, MJ Montero, C Martínez-Salgado, JM López-Novoa, FJ López-Hernández
PloS one 2014
Tipping the balance from angiogenesis to fibrosis in CKD
BJ Ballermann, M Obeidat
Kidney International Supplements 2014
Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes
D Thomasova, HA Bruns, V Kretschmer, M Ebrahim, S Romoli, H Liapis, AM Kotb, N Endlich, HJ Anders
Journal of the American Society of Nephrology : JASN 2014
Animal models of regression/progression of kidney disease
BJ Lim, HC Yang, AB Fogo
Drug Discovery Today: Disease Models 2014
Clinicopathological assessment of the nephron number
N Tsuboi, G Kanzaki, K Koike, T Kawamura, M Ogura, T Yokoo
Clinical Kidney Journal 2014
Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review.
Chen YZ, Gong ZX, Cai GY, Gao Q, Chen XM, Tang L, Wei RB, Zhou JH
Chinese Journal of Integrative Medicine 2014
[Consensus document for the detection and management of chronic kidney disease].
Martínez-Castelao A, Górriz JL, Bover J, Segura-de la Morena J, Cebollada J, Escalada J, Esmatjes E, Fácila L, Gamarra J, Gràcia S, Hernández-Moreno J, Llisterri-Caro JL, Mazón P, Montañés R, Morales-Olivas F, Muñoz-Torres M, de Pablos-Velasco P, de Santiago A, Sánchez-Celaya M, Suárez C, Tranche S
2014
Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes.
Bjornstad P, Maahs DM, Cherney DZ, Cree-Green M, West A, Pyle L, Nadeau KJ
Diabetes care 2014
Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis.
Inker LA, Levey AS, Pandya K, Stoycheff N, Okparavero A, Greene T
American journal of kidney diseases : the official journal of the National Kidney Foundation 2014
Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.
Sandholm N, Forsblom C, Mäkinen VP, McKnight AJ, Osterholm AM, He B, Harjutsalo V, Lithovius R, Gordin D, Parkkonen M, Saraheimo M, Thorn LM, Tolonen N, Wadén J, Tuomilehto J, Lajer M, Ahlqvist E, Möllsten A, Marcovecchio ML, Cooper J, Dunger D, Paterson AD, Zerbini G, Groop L, Tarnow L, Maxwell AP, Tryggvason K, Groop PH
Diabetologia 2014
Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.
Fujita D, Takahashi M, Doi K, Abe M, Tazaki J, Kiyosue A, Myojo M, Ando J, Fujita H, Noiri E, Sugaya T, Hirata Y, Komuro I
Heart and Vessels 2014
Proteinuria Impairs Podocyte Regeneration by Sequestering Retinoic Acid
A Peired, ML Angelotti, E Ronconi, G Marca, B Mazzinghi, A Sisti, D Lombardi, E Giocaliere, MD Bona, F Villanelli, E Parente, L Ballerini, C Sagrinati, N Wanner, TB Huber, H Liapis, E Lazzeri, L Lasagni, P Romagnani
Journal of the American Society of Nephrology : JASN 2013
Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS
J Zhang, JW Pippin, RD Krofft, S Naito, ZH Liu, SJ Shankland
American journal of physiology. Renal physiology 2013
Danger control programs cause tissue injury and remodeling
JH Hagemann, H Haegele, S Müller, HJ Anders
International journal of molecular sciences 2013
Pathophysiology of proteinuria and its value as an outcome measure in CKD: Proteinuria in CKD
P Cravedi, G Remuzzi
British Journal of Clinical Pharmacology 2013
Renal progenitors: an evolutionary conserved strategy for kidney regeneration
P Romagnani, L Lasagni, G Remuzzi
Nature Reviews Nephrology 2013
Associations between structural and functional changes to the kidney in diabetic humans and mice
DW Powell, DN Kenagy, S Zheng, SC Coventry, J Xu, L Cai, EC Carlson, PN Epstein
Life Sciences 2013
Measurement of renal function in patients with chronic kidney disease: Renal function in CKD
EA Sandilands, N Dhaun, JW Dear, DJ Webb
2013
Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors
C Zou, R Xie, Y Bao, X Liu, M Sui, S M, S Li, H Yin
Endocrine 2013
Podocyte mitosis - a catastrophe.
Lasagni L, Lazzeri E, Shankland SJ, Anders HJ, Romagnani P
Current molecular medicine 2013
Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney
GC Gobe, C Morais, DA Vesey, DW Johnson
Journal of Nephropathology 2013
Isolating glomeruli from mice: A practical approach for beginners
X Liu, Q Fan, G Yang, N Liu, D Chen, Y Jiang, L Wang
Experimental and therapeutic medicine 2013
Nephropathy and Elevated BP in Mice with Podocyte-Specific NADPH Oxidase 5 Expression
CE Holterman, JF Thibodeau, C Towaij, A Gutsol, AC Montezano, RJ Parks, ME Cooper, RM Touyz, CR Kennedy
Journal of the American Society of Nephrology : JASN 2013
Chapter 1: Definition and classification of CKD.
Kidney International Supplements 2013
Niacin in patients with chronic kidney disease: Is it effective and safe?
Park CW
Kidney Research and Clinical Practice 2013
Basic research: Podocyte progenitors and ectopic podocytes.
Lasagni L, Romagnani P
Nature reviews. Nephrology 2013
The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
Aminzadeh MA, Reisman SA, Vaziri ND, Khazaeli M, Yuan J, Meyer CJ
Xenobiotica; the fate of foreign compounds in biological systems 2013
Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction.
Groop PH, Cooper ME, Perkovic V, Emser A, Woerle HJ, von Eynatten M
Diabetes care 2013
Effect of castration on renal glycosaminoglycans and their urinary excretion in male and female rats with chronic renal failure.
Lemos CC, Tovar AM, Guimarães MA, Bregman R
2013
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Ohsawa M, Tamura K, Kanaoka T, Wakui H, Maeda A, Dejima T, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Toya Y, Fujikawa T, Umemura S
International journal of molecular sciences 2013
Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy
Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND
Nephrology Dialysis Transplantation 2013
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes: The TODAY clinical trial
Diabetes care 2013
Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study
Rognant N, Alamartine E, Aldigier JC, Combe C, Vendrely B, Deteix P, Cluzel P, Juillard L, Vrtovsnik F, Maurice C, Fave S, Laville M
BMC Nephrology 2013
Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis
Mirković K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, van den Born J, Navis G, de Borst MH
PloS one 2013
MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition
D Macconi, S Tomasoni, P Romagnani, P Trionfini, F Sangalli, B Mazzinghi, P Rizzo, E Lazzeri, M Abbate, G Remuzzi, A Benigni
Journal of the American Society of Nephrology : JASN 2012
A transcriptional network underlies susceptibility to kidney disease progression
D Laouari, M Burtin, A Phelep, F Bienaime, LH Noel, DC Lee, C Legendre, G Friedlander, M Pontoglio, F Terzi
EMBO Molecular Medicine 2012
Endothelin and the podocyte
M Barton, PL Tharaux
Clinical Kidney Journal 2012
Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy
A Mima, M Kitada, P Geraldes, Q Li, M Matsumoto, K Mizutani, W Qi, C Li, M Leitges, C Rask-Madsen, GL King
The FASEB Journal 2012
Four danger response programs determine glomerular and tubulointerstitial kidney pathology
HJ Anders
Organogenesis 2012
Inhibition of renin activity slows down the progression of HIV-associated nephropathy
D Kumar, A Plagov, I Yadav, DD Torri, S Sayeneni, A Sagar, P Rai, M Adabala, R Lederman, N Chandel, G Ding, A Malhotra, PC Singhal
American journal of physiology. Renal physiology 2012
Proteinuria should be used as a surrogate in CKD
P Cravedi, P Ruggenenti, G Remuzzi
Nature Reviews Nephrology 2012
Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes
M Flaquer, M Franquesa, A Vidal, N Bolaños, J Torras, N Lloberas, I Herrero-Fresneda, JM Grinyó, JM Cruzado
Diabetologia 2012
Renal stem cells: fact or science fiction?
KK McCampbell, RA Wingert
Biochemical Journal 2012
Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling
JY Choi, TS Ha, HY Park, HY Ahn
Clinical and Experimental Nephrology 2012
Low-protein diet improves blood and urinary glucose levels and renal manifestations of diabetes in C57BLKS-db/db mice
E Arimura, M Horiuchi, H Kawaguchi, N Miyoshi, K Aoyama, T Takeuchi
European Journal of Nutrition 2012
Searching for new care models for chronic kidney disease
Shah AP, Mehrotra R
Kidney International 2012
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease
Yanagi M, Tamura K, Fujikawa T, Wakui H, Kanaoka T, Ohsawa M, Azushima K, Maeda A, Kobori H, Umemura S
Hypertension research : official journal of the Japanese Society of Hypertension 2012
GWAS of Diabetic Nephropathy: Is the GENIE out of the Bottle?
Böger CA, Sedor JR
PLoS genetics 2012
Rituximab in Idiopathic Membranous Nephropathy
Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Marasà M, Remuzzi G
Journal of the American Society of Nephrology : JASN 2012
Clinical Utility of Creatinine- and Cystatin C–Based Definition of Renal Function for Risk Prediction of Primary Cardiovascular Events in Patients With Diabetes
Schöttker B, Herder C, Müller H, Brenner H, Rothenbacher D
Diabetes care 2012
Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome
Piccoli GB, Bonino LD, Campisi P, Vigotti FN, Ferraresi M, Fassio F, Brocheriou I, Porpiglia F, Restagno G
BMC Nephrology 2012
[Albuminuria : prognostic marker or therapeutic goal?].
Chatzikyrkou C, Haller H, Menne J
Der Internist 2012
Inhibiting Angiotensin-Converting Enzyme Promotes Renal Repair by Limiting Progenitor Cell Proliferation and Restoring the Glomerular Architecture
A Benigni, M Morigi, P Rizzo, E Gagliardini, C Rota, M Abbate, S Ghezzi, A Remuzzi, G Remuzzi
The American Journal of Pathology 2011
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications
JM López-Novoa, AB Rodríguez-Peña, A Ortiz, C Martínez-Salgado, FJ Hernández
Journal of Translational Medicine 2011
The role of cell plasticity in progression and reversal of renal fibrosis
JC Dussaule, D Guerrot, AC Huby, C Chadjichristos, N Shweke, JJ Boffa, C Chatziantoniou
International Journal of Experimental Pathology 2011
Fibrinogen-like protein 2 expression correlates with microthrombosis in rats with type 2 diabetic nephropathy
G Su, K Liu, Y Wang, J Wang, X Li, W Li, Y Liao, Z Wang
Journal of Biomedical Research 2011
Addition of Atrasentan to Renin-Angiotensin System Blockade Reduces Albuminuria in Diabetic Nephropathy
DE Kohan, Y Pritchett, M Molitch, S Wen, T Garimella, P Audhya, DL Andress
Journal of the American Society of Nephrology : JASN 2011
The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling
L He, Y Qi, X Rong, J Jiang, Q Yang, J Yamahara, M Murray, Y Li
Evidence-based complementary and alternative medicine : eCAM 2011
Adverse Host Factors Exacerbate Occult HIV-Associated Nephropathy
D Kumar, D Salhan, S Magoon, DD Torri, S Sayeneni, A Sagar, A Bandhlish, A Malhotra, PN Chander, PC Singhal
The American Journal of Pathology 2011
Proteins and renal fibrosis: low-protein diets induce Kruppel-like factor-15, limiting renal fibrosis
Y Wang, WE Mitch
Kidney International 2011
Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II–mediated podocyte apoptosis
HH Hsu, S Hoffmann, GS di Marco, N Endlich, J Peter-Katalinić, T Weide, H Pavenstädt
Kidney International 2011
Managing kidney disease with blood-pressure control
E Wühl, F Schaefer
Nature Reviews Nephrology 2011
Fluorescent Microangiography Is a Novel and Widely Applicable Technique for Delineating the Renal Microvasculature
A Advani, KA Connelly, DA Yuen, Y Zhang, SL Advani, J Trogadis, MG Kabir, E Shachar, MA Kuliszewski, H Leong-Poi, DJ Stewart, RE Gilbert
PloS one 2011
PKCβ-induced Selective IRS1 Dysfunction and Insulin Resistance in Renal Glomeruli of Rodent Models of Diabetes and Obesity
A Mima, Y Ohshiro, M Kitada, M Matsumoto, P Geraldes, C Li, Q Li, G White, C Cahill, C Rask-Madsen, GL King
Kidney International 2011
Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
LC Matavelli, J Huang, HM Siragy
Hypertension 2011
Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
Rao RP, Singh A, Jain AK, Srinivasan BP
Journal of Biomedical Research 2011
Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study
Kawashima M, Wada K, Ohta H, Terawaki H, Aizawa Y
BMC Nephrology 2011
Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
Selvarajah S, vD Graaf Y, Visseren FL, Bots ML
BMC Cardiovascular Disorders 2011
Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens.
Garcia-Roig M, Gorin MA, Parra-Herran C, Garcia-Buitrago M, Kava BR, Jorda M, Soloway MS, Manoharan M, Ciancio G
World Journal of Urology 2011
Chronic kidney disease: Staging CKD: can we rely on estimated GFRs?
Ruggenenti P, Remuzzi G
Nature reviews. Nephrology 2011
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
Amandine Viau, Khalil El Karoui, Denise Laouari, Martine Burtin, Clement Nguyen, Kiyoshi Mori, Evangeline Pillebout, Thorsten Berger, Tak W. Mak, Bertrand Knebelmann, Gerard Friedlander, Jonathan Barasch, Fabiola Terzi
Journal of Clinical Investigation 2010
Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders
L Lasagni, L Ballerini, ML Angelotti, E Parente, C Sagrinati, B Mazzinghi, A Peired, E Ronconi, F Becherucci, D Bani, M Gacci, M Carini, E Lazzeri, P Romagnani
Stem Cells 2010
TGF-α Mediates Genetic Susceptibility to Chronic Kidney Disease
D Laouari, M Burtin, A Phelep, C Martino, E Pillebout, X Montagutelli, G Friedlander, F Terzi
Journal of the American Society of Nephrology : JASN 2010
The RAAS in the pathogenesis and treatment of diabetic nephropathy
P Ruggenenti, P Cravedi, G Remuzzi
Nature Reviews Nephrology 2010
The role of renin angiotensin system inhibition in kidney repair
IM van der Meer, P Cravedi, G Remuzzi
Fibrogenesis & Tissue Repair 2010
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice
M Albiero, L Menegazzo, E Boscaro, C Agostini, A Avogaro, GP Fadini
Diabetologia 2010
HDL metabolism and activity in chronic kidney disease
ND Vaziri, M Navab, AM Fogelman
Nature Reviews Nephrology 2010
The Anti-Fibrotic Effect of Mycophenolic Acid–Induced Neutral Endopeptidase
MP Dell'Oglio, G Zaza, M Rossini, C Divella, P Pontrelli, R Verrienti, M Rutigliano, P Ditonno, P Stifanelli, N Ancona, FP Schena, G Grandaliano
Journal of the American Society of Nephrology : JASN 2010
Mitigation of radiation injuries via suppression of the renin-angiotensin system: Emphasis on radiation nephropathy
Cohen EP, Fish BL, Moulder JE
Current drug targets 2010
Avosentan for Overt Diabetic Nephropathy
Mann JF, Green D, Jamerson K, Ruilope LM, Kuranoff SJ, Littke T, Viberti G
Journal of the American Society of Nephrology : JASN 2010
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy
Z Tang, B Lu, E Hatch, SH Sacks, NS Sheerin
Journal of the American Society of Nephrology : JASN 2009
Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury
T Tanaka, K Doi, R Maeda-Mamiya, K Negishi, D Portilla, T Sugaya, T Fujita, E Noiri
The American Journal of Pathology 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro
M Motojima, T Matsusaka, V Kon, I Ichikawa
Nephron. Experimental nephrology 2009
Possible mechanisms of kidney repair
P Romagnani, R Kalluri
Fibrogenesis & Tissue Repair 2009
Toward the identification of a "renopoietic system"?
P Romagnani
Stem Cells 2009
Angiotensin receptors as determinants of life span
P Cassis, S Conti, G Remuzzi, A Benigni
Pflügers Archiv - European Journal of Physiology 2009
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
T Okada, T Sakaguchi, I Hatamura, F Saji, S Negi, H Otani, Y Muragaki, H Kawachi, T Shigematsu
Clinical and Experimental Nephrology 2009
Intensified inhibition of renin-angiotensin system: A way to improve renal protection?
P Cravedi, P Ruggenenti, G Remuzzi
Current Hypertension Reports 2009
Intensified inhibition of renin-angiotensin system: A way to improve renal protection?
P Cravedi, P Ruggenenti, G Remuzzi
Current Hypertension Reports 2009
Omega-3 and Renal Function in Older Adults
Lauretani F, Maggio M, Pizzarelli F, Michelassi S, Ruggiero C, Ceda GP, Bandinelli S, Ferrucci L
Current pharmaceutical design 2009
Dual renin-angiotensin system blockade in the ONTARGET study: clinically relevant risk for the kidney?
Chaudhary K, Nistala R, Whaley-Connell A
Current Hypertension Reports 2009
[Cardiovascular disease, renal disease and other chronic diseases. Earlier intervention is needed in chronic renal disease].
Martín de Francisco ÁL, Aguilera García L, Fuster Carulla V
2009
Proteinuria: Increased angiotensin-receptor blocking is not the first option.
Ruggenenti P, Cravedi P, Remuzzi G
Nature reviews. Nephrology 2009
Regeneration of glomerular podocytes by human renal progenitors
E Ronconi, C Sagrinati, ML Angelotti, E Lazzeri, B Mazzinghi, L Ballerini, E Parente, F Becherucci, M Gacci, M Carini, E Maggi, M Serio, GB Vannelli, L Lasagni, S Romagnani, P Romagnani
Journal of the American Society of Nephrology : JASN 2008
Mechanisms of angiotensin II signaling on cytoskeleton of podocytes
HH Hsu, S Hoffmann, N Endlich, A Velic, A Schwab, T Weide, E Schlatter, H Pavenstädt
Journal of Molecular Medicine 2008
Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
Fervenza FC, Torra R, Warnock DG
Biologics : targets & therapy 2008
MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS
Nature Genetics 2008
Role of remission clinics in the longitudinal treatment of CKD.
Ruggenenti P, Perticucci E, Cravedi P, Gambara V, Costantini M, Sharma SK, Perna A, Remuzzi G
Journal of the American Society of Nephrology : JASN 2008
Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.
Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, Makino H, Hishida A
Clinical and Experimental Nephrology 2008
Does remission of renal disease associated with antihypertensive treatment exist?
P Cravedi, P Ruggenenti, G Remuzzi
Current Hypertension Reports 2007
Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension.
Wallace C, Xue MZ, Newhouse SJ, Marcano AC, Onipinla AK, Burke B, Gungadoo J, Dobson RJ, Brown M, Connell JM, Dominiczak A, Lathrop GM, Webster J, Farrall M, Mein C, Samani NJ, Caulfield MJ, Clayton DG, Munroe PB
The American Journal of Human Genetics 2006

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 8 X users
Referenced in 3 patents
303 readers on Mendeley
1 readers on CiteULike
See more details